Transcriptional control of stress-induced resistance to retinal degeneration
应激诱导的视网膜变性抵抗力的转录控制
基本信息
- 批准号:10842755
- 负责人:
- 金额:$ 38.37万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-09-01 至 2026-08-31
- 项目状态:未结题
- 来源:
- 关键词:AffectAge related macular degenerationBindingBlindnessCell DeathCellsCessation of lifeChIP-seqCytoprotectionDataData SetDiseaseDisease ClusteringsFGF2 geneGene ExpressionGenesGenetic TranscriptionGliosisIndividualInflammationInflammatoryInjectionsInjuryKnockout MiceKnowledgeLIF geneLIFR geneLeadLightMediatingMethodsMicrogliaModelingMuller&aposs cellMusMutationNF-kappa BPathologicPersonsPhotoreceptorsPhototransductionPlayPublicationsPublishingQuality of lifeRegulationResearchResistanceRetinaRetinal DegenerationRodRoleSignal TransductionSiteSortingStressTechniquesTestingTissuesTranscription CoactivatorTranscriptional ActivationTranscriptional RegulationTransducersUnited StatesWorkantagonistbiological adaptation to stresscell typecytokinedata integrationdesigndifferential expressioninherited retinal degenerationinjuredmigrationnovel therapeuticspromoterreceptorresponseretinal neuronretinal rodssingle-cell RNA sequencingstress statetranscription factor
项目摘要
Abstract:
Retinal degenerations are a large cluster of diseases characterized by the irreversible loss of
photoreceptors. The death of these cells results in a permanent loss of vision that can have debilitating
impacts on an individual's quality of life. Despite the diversity among triggers for retinal degenerations, the
mechanisms surrounding photoreceptor death are often similar, suggesting the possibility of developing
gene/mutation-independent approaches to reduce blindness from multiple forms of retinal degeneration. We
and others have shown that STAT3 is activated in all retinal cells, including photoreceptors and Müller cells
during inherited retinal degeneration. Additional work has shown that activation of STAT3 plays an essential
role in promoting a wide array of gene expression changes to increase the cell’s capacity to resist cell death.
However, despite these impressive findings, little progress has been made in identifying the mechanisms by
which STAT3 regulates protection. In this project, we will use state of the art techniques including single-cell
RNA-seq and integrating the data with cell-specific ChIP-seq to comprehensively identify all genes and
transcriptional networks regulated by STAT3 in retinal Müller cells and rods.
抽象的:
视网膜变性是一大类疾病,其特征是视网膜不可逆性丧失。
光感受器。这些细胞的死亡会导致视力永久性丧失,从而使人衰弱
对个人生活质量的影响。尽管视网膜变性的诱因多种多样,
光感受器死亡的机制通常是相似的,这表明发生光感受器死亡的可能性
与基因/突变无关的方法可减少多种形式的视网膜变性导致的失明。我们
等人表明 STAT3 在所有视网膜细胞中都被激活,包括感光细胞和穆勒细胞
在遗传性视网膜变性期间。其他工作表明 STAT3 的激活起着至关重要的作用
在促进广泛的基因表达变化以增加细胞抵抗细胞死亡的能力中发挥作用。
然而,尽管有这些令人印象深刻的发现,但在确定其机制方面却进展甚微。
STAT3 调节保护。在这个项目中,我们将使用最先进的技术,包括单细胞
RNA-seq 并将数据与细胞特异性 ChIP-seq 相结合,以全面识别所有基因和
视网膜 Müller 细胞和视杆细胞中受 STAT3 调节的转录网络。
项目成果
期刊论文数量(1)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Overexpression of Nfe2l1 increases proteasome activity and delays vision loss in a preclinical model of human blindness.
- DOI:10.1126/sciadv.add5479
- 发表时间:2023-07-14
- 期刊:
- 影响因子:13.6
- 作者:
- 通讯作者:
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
John D Ash其他文献
John D Ash的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('John D Ash', 18)}}的其他基金
Dual Targeting Mitochondria and GPCR in Retinal Protection
双靶向线粒体和 GPCR 在视网膜保护中的作用
- 批准号:
10383538 - 财政年份:2022
- 资助金额:
$ 38.37万 - 项目类别:
Transcriptional control of stress-induced resistance to retinal degeneration
应激诱导的视网膜变性抵抗力的转录控制
- 批准号:
10477262 - 财政年份:2021
- 资助金额:
$ 38.37万 - 项目类别:
Transcriptional control of stress-induced resistance to retinal degeneration
应激诱导的视网膜变性抵抗力的转录控制
- 批准号:
10296291 - 财政年份:2021
- 资助金额:
$ 38.37万 - 项目类别:
Regulators of retinal metabolism in healthy and degenerating retinas
健康和退化视网膜中视网膜代谢的调节剂
- 批准号:
10028851 - 财政年份:2020
- 资助金额:
$ 38.37万 - 项目类别:
Regulators of retinal metabolism in healthy and degenerating retinas
健康和退化视网膜中视网膜代谢的调节剂
- 批准号:
10455542 - 财政年份:2020
- 资助金额:
$ 38.37万 - 项目类别:
Regulators of retinal metabolism in healthy and degenerating retinas
健康和退化视网膜中视网膜代谢的调节剂
- 批准号:
10247603 - 财政年份:2020
- 资助金额:
$ 38.37万 - 项目类别:
Regulators of retinal metabolism in healthy and degenerating retinas
健康和退化视网膜中视网膜代谢的调节剂
- 批准号:
10834510 - 财政年份:2020
- 资助金额:
$ 38.37万 - 项目类别:
Administrative Supplement to Regulators of retinal metabolism in healthy and degenerating retinas
健康和退化视网膜视网膜代谢调节剂的行政补充
- 批准号:
10361928 - 财政年份:2020
- 资助金额:
$ 38.37万 - 项目类别:
Comparative transcriptomic and epigenomic analyses of Muller glia reprogramming
Muller 胶质细胞重编程的比较转录组和表观基因组分析
- 批准号:
9551199 - 财政年份:2016
- 资助金额:
$ 38.37万 - 项目类别:
相似海外基金
I(eye)-SCREEN: A real-world AI-based infrastructure for screening and prediction of progression in age-related macular degeneration (AMD) providing accessible shared care
I(eye)-SCREEN:基于人工智能的现实基础设施,用于筛查和预测年龄相关性黄斑变性 (AMD) 的进展,提供可及的共享护理
- 批准号:
10102692 - 财政年份:2024
- 资助金额:
$ 38.37万 - 项目类别:
EU-Funded
Inhibiting Neovascularization and Subretinal Fibrosis in Neovascular Age-Related Macular Degeneration
抑制新生血管性年龄相关性黄斑变性的新生血管形成和视网膜下纤维化
- 批准号:
10639785 - 财政年份:2023
- 资助金额:
$ 38.37万 - 项目类别:
Inhibition of melanogenesis in retinal pigment epithelium, a contributing factor in age-related macular degeneration
抑制视网膜色素上皮中的黑色素生成,这是年龄相关性黄斑变性的一个促成因素
- 批准号:
23K09052 - 财政年份:2023
- 资助金额:
$ 38.37万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Deciphering the role of osteopontin in the aging eye and age-related macular degeneration
破译骨桥蛋白在眼睛老化和年龄相关性黄斑变性中的作用
- 批准号:
10679287 - 财政年份:2023
- 资助金额:
$ 38.37万 - 项目类别:
Evaluation of New Anti-inflammatory Treatments for Age-Related Macular Degeneration
年龄相关性黄斑变性的新型抗炎治疗方法的评价
- 批准号:
10642988 - 财政年份:2023
- 资助金额:
$ 38.37万 - 项目类别:
Progression of Early Atrophic Lesions in Age-related Macular degeneration
年龄相关性黄斑变性早期萎缩性病变的进展
- 批准号:
10635325 - 财政年份:2023
- 资助金额:
$ 38.37万 - 项目类别:
Cellular and molecular mechanisms of AIM2 and NLRP3 inflammasome activation in age-related macular degeneration
年龄相关性黄斑变性中 AIM2 和 NLRP3 炎症小体激活的细胞和分子机制
- 批准号:
10584110 - 财政年份:2023
- 资助金额:
$ 38.37万 - 项目类别:
Elucidation of roles of mast cells and macrophages in the pathogenesis of age-related macular degeneration
阐明肥大细胞和巨噬细胞在年龄相关性黄斑变性发病机制中的作用
- 批准号:
22H03243 - 财政年份:2022
- 资助金额:
$ 38.37万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
AMD Mitochondria Modulate Expression of microRNA 135b-5p and 148a-3p in RPE Cybrids: Implications for Age-related Macular Degeneration
AMD 线粒体调节 RPE Cybrids 中 microRNA 135b-5p 和 148a-3p 的表达:对年龄相关性黄斑变性的影响
- 批准号:
10433610 - 财政年份:2022
- 资助金额:
$ 38.37万 - 项目类别:
Targeting the inflammatory response in age-related macular degeneration
针对年龄相关性黄斑变性的炎症反应
- 批准号:
10504138 - 财政年份:2022
- 资助金额:
$ 38.37万 - 项目类别:














{{item.name}}会员




